Erythromycin Use in Pregnancy

When talking about erythromycin use in pregnancy, the practice of prescribing the macrolide antibiotic erythromycin to pregnant women for bacterial infections. Also known as erythromycin during pregnancy, it sits at the crossroads of maternal health and fetal safety. This erythromycin use in pregnancy encompasses treatment of infections like chlamydia, whooping cough, and certain skin conditions. It requires a clear view of how the drug crosses the placenta, because the degree of placental transfer determines fetal exposure. Moreover, antibiotics, medicines that fight bacterial infections as a broader class influence prescribing choices, while placental transfer, the movement of substances from mother to fetus through the placenta shapes safety assessments. Understanding these links helps clinicians balance the need to clear maternal infection against the goal of minimizing fetal risk.